Patients with inflammatory arthritis reported significant loneliness and longed for their doctors to recognize their ...

Among small-molecule drugs, upadacitinib and deucravacitinib demonstrate the best efficacy for treatment of psoriatic ...

Patients receiving an immune checkpoint inhibitor for a neoplasm face an increased risk for rheumatoid arthritis, an ...

Get an expert’s answers to common questions about how physical therapy can help with psoriatic arthritis, and learn how to get started. Living with psoriatic arthritis can mean chronic joint ...

Tilt is a new makeup brand with products designed to make beauty accessible to everyone. It’s the first beauty brand and ...

Understand RA from early to advanced stages. Explore symptoms, treatments, and lifestyle tips to manage rheumatoid arthritis ...

SECUKINUMAB (SECU) demonstrates sustained effectiveness and high drug survival rates in patients with moderate-to-severe ...

This feature is a deep dive into the challenges of defining and treating Difficult-to-Treat Rheumatoid Arthritis (D2T-RA).

Background Upadacitinib is a Janus kinase inhibitor under evaluation for the treatment of psoriatic arthritis (PsA). We evaluated upadacitinib in patients with PsA and prior inadequate response or ...

Bosman’s surgery, as well as his psoriatic arthritis (PsA) and osteoarthritis (OA), left him unable to continue his vigorous gym workout routine. “I was looking for something that was low-impact and ...

Clinical and Radiographic Outcomes of Four Different Treatment Strategies in Patients With Early Rheumatoid Arthritis (the Best Study): A Randomized, Controlled Trialfrom Arthritis & Rheumatism.